RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Just to echo Gfp's perspective here: That oft-cited price target dates from a time that Cortex had about 16 million shares out--and in fact in March 2000, reached 8.13 per share. Had it reached that target, the market cap would have been $192 million. Depending on what options/warrants would be in the money--we can only hope more of them eventually will be-- that would mean a contemporary share price of under $2.00 per share to achieve the same valuation for the company.

NeuroInvestment